Polycystic Ovary
Use of Rosiglitazone for Clomiphene Resistant Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
... Polycystic Ovary Syndrome (PCOS) is complicated by the complexity of the pathophysiological interaction and heterogeneity of the clinical expression. The exact etiology of PCOS still remains unclear (Dunaif ...
10
The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta analysis
... Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy, affecting 4 – 12% of reproductive-aged women. Women with PCOS often exhibit many metabolic abnormalities that are associated ...
7
A life course perspective on polycystic ovary syndrome
... Abstract: Polycystic ovary syndrome (PCOS) is a major public health problem in the US. Worldwide, the public is largely unaware of the condition and health care providers do not seem to fully understand it. ...
8
Treatment options for polycystic ovary syndrome
... Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. Its prevalence among infertile women is 15%–20%. The etiology of PCOS remains unclear; however, several studies have ...
11
The Diagnosis of Polycystic Ovary Syndrome in Adolescents
... abstract Consensus has recently been reached by international pediatric subspecialty societies that otherwise unexplained persistent hyperandrogenic anovulation using age- and stage-appropriate standards are appropriate ...
14
Polycystic Ovary Syndrome (PCOS) and Fertility
... The polycystic ovary syndrome (PCOS) is defined as a combination of hyperandrogenism (hirsut- ism and acne) and anovulation (oligomenorrhea, infertility, and dysfunctional uterine bleeding), with or without ...
8
Polycystic Ovary Syndrome and the Metabolic Syndrome
... As national attention is focused on the emerging epidemic of type 2 diabetes and obesity, more energy is being direct- ed toward earlier detection, improved therapies, and potential prevention. One condition commonly ...
8
Polycystic ovary syndrome and mitochondrial dysfunction
... Polycystic ovary syndrome (PCOS) is a prevalent hormonal disorder of premenopausal women worldwide and is characterized by reproductive, endocrine, and metabolic ...ovarian polycystic changes, and ...
15
A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
... PCOS: polycystic ovary syndrome; PCOM: polycystic ovarian morphology; EXD: Erxian decoction; TCMSP: traditional Chinese medicine system pharmacology analysis platform; GO: Biological Network Gene ...
12
Genetics of polycystic ovary syndrome
... Polycystic ovary syndrome (PCOS) is a genetically based disorder which reflects multiple potential aetiologies and variable clinical presentations. It is clearly a heterogeneous syndrome, and current ...
6
Epidemiology, diagnosis, and management of polycystic ovary syndrome
... of 50 women (26%) with epilepsy. Among the 16 patients who were not treated for epilepsy at presentation, five (31%) were diagnosed with PCOS, supporting the contention that epilepsy, independent of antiepileptic drugs, ...
13
Role of Statin Drugs for Polycystic Ovary Syndrome
... included polycystic ovary syndrome, PCOS, hydroxymethylglutaryl-CoA reductase inhibitors, hydroxymethylglutaryl-CoA, statin, atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, ...
11
Clinical and Endocrine Profiles of 62 Malaysian Women with Polycystic Ovary Syndrome
... Clinical and Endocrine Profiles of 62 Malaysian Women with Polycystic Ovary Syndrome Med J Malaysia Vo! 44 No 4 December 1989 Clinical and endocrine profiles of 62 Malaysian women with polycystic ovar[.] ...
5
A Study on Insulin Resistance in Polycystic Ovary Syndrome.
... The polycystic ovary is usually enlarged and characterised by a smooth pearly white capsule. The surface area is doubled and this gives an increase of 2.8 times the average volume. Same number of primordial ...
72
Psychological investigation in patients with polycystic ovary syndrome
... Background: The aim of the present study was to estimate the prevalence of mood disorders and examine a range of predictors for psychological well-being among Iranian women with polycystic ovary syndrome ...
8
Optimal management of subfertility in polycystic ovary syndrome
... with polycystic ovary syndrome. Defining polycystic ovary syndrome in a patient requires first investigating other possible causes for polycystic ovary morphology, acne, ...
9
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
... Polycystic ovary syndrome (PCOS) is a common metabolic and endocrine disorder affecting 6 to 21% of reproductive aged women depending on population, mean body mass index (BMI) and diagnostic criteria used ...
331
Anti-mullerian hormone and antral follicle count in polycystic ovary syndrome and non-polycystic ovary syndrome women
... of polycystic ovary syndrome remains obscure, the distinctive feature is the failure of follicular maturation resulting in an ovulation and accumulation of preantral and small antral follicles which ...
8
A PROSPECTIVE STUDY ON THE EFFECTIVENESS OF METFORMIN AND ETHINYL ESTRADIOL CYPROTERONE ACETATE IN THE MANAGEMENT OF HYPERANDROGENISM IN POLYCYSTIC OVARY SYNDROME PATIENTS
... Polycystic Ovary Syndrome characterized by hyperandrogenism, hyperinsulinemia and menstrual dysfunction is the most common endocrine disorder among ...the ovary is the reason for the release of ...
17
Subclinical Eating Disorder, Polycystic Ovary Syndrome Is there Any Connection Between these Two Conditions Through Leptin A Twin Study
... Subclinical Eating Disorder, Polycystic Ovary Syndrome Is There Any Connection Between These Two Conditions Through Leptin A Twin Study ORIGINAL ARTICLE Subclinical Eating Disorder, Polycystic Ovary S[.] ...
6